PL2076494T3 - Podstawione przez piperydynę lub piperazynę pochodne kwasu tetrahydronaftaleno-1-karboksylowego hamujące MTP - Google Patents
Podstawione przez piperydynę lub piperazynę pochodne kwasu tetrahydronaftaleno-1-karboksylowego hamujące MTPInfo
- Publication number
- PL2076494T3 PL2076494T3 PL07821650T PL07821650T PL2076494T3 PL 2076494 T3 PL2076494 T3 PL 2076494T3 PL 07821650 T PL07821650 T PL 07821650T PL 07821650 T PL07821650 T PL 07821650T PL 2076494 T3 PL2076494 T3 PL 2076494T3
- Authority
- PL
- Poland
- Prior art keywords
- piperidine
- naphthalene
- carboxylic acid
- inhibiting compounds
- substituted tetrahydro
- Prior art date
Links
- NQRYJNQNLNOLGT-UHFFFAOYSA-N Piperidine Chemical group C1CCNCC1 NQRYJNQNLNOLGT-UHFFFAOYSA-N 0.000 title 2
- VDLWTJCSPSUGOA-UHFFFAOYSA-N 1,2,3,4-tetrahydronaphthalene-1-carboxylic acid Chemical class C1=CC=C2C(C(=O)O)CCCC2=C1 VDLWTJCSPSUGOA-UHFFFAOYSA-N 0.000 title 1
- 150000001875 compounds Chemical class 0.000 title 1
- GLUUGHFHXGJENI-UHFFFAOYSA-N diethylenediamine Chemical group C1CNCCN1 GLUUGHFHXGJENI-UHFFFAOYSA-N 0.000 title 1
- 230000002401 inhibitory effect Effects 0.000 title 1
- 125000004193 piperazinyl group Chemical group 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
- C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
- C07D241/10—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
- C07D241/14—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D241/20—Nitrogen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/56—Nitrogen atoms
- C07D211/58—Nitrogen atoms attached in position 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/10—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by doubly bound oxygen or sulphur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Child & Adolescent Psychology (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP06122817 | 2006-10-24 | ||
| EP07821650A EP2076494B1 (en) | 2006-10-24 | 2007-10-22 | Piperidine or piperazine substituted tetrahydro-naphthalene-1-carboxylic acid mtp inhibiting compounds |
| PCT/EP2007/061286 WO2008049806A1 (en) | 2006-10-24 | 2007-10-22 | Piperidine or piperazine substituted tetrahydro-naphthalene-1-carboxylic acid mtp inhibiting compounds |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL2076494T3 true PL2076494T3 (pl) | 2011-01-31 |
Family
ID=37885794
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL07821650T PL2076494T3 (pl) | 2006-10-24 | 2007-10-22 | Podstawione przez piperydynę lub piperazynę pochodne kwasu tetrahydronaftaleno-1-karboksylowego hamujące MTP |
Country Status (27)
| Country | Link |
|---|---|
| US (1) | US8114880B2 (pl) |
| EP (1) | EP2076494B1 (pl) |
| JP (1) | JP5506085B2 (pl) |
| KR (1) | KR101415536B1 (pl) |
| CN (1) | CN101528695B (pl) |
| AR (1) | AR063517A1 (pl) |
| AT (1) | ATE475648T1 (pl) |
| AU (1) | AU2007310925B2 (pl) |
| BR (1) | BRPI0717357A2 (pl) |
| CA (1) | CA2664141C (pl) |
| CL (1) | CL2007003042A1 (pl) |
| CY (1) | CY1111010T1 (pl) |
| DE (1) | DE602007008124D1 (pl) |
| DK (1) | DK2076494T3 (pl) |
| EA (1) | EA016311B1 (pl) |
| IL (1) | IL198332A (pl) |
| JO (1) | JO2653B1 (pl) |
| MX (1) | MX2009004386A (pl) |
| NO (1) | NO20092005L (pl) |
| NZ (1) | NZ575615A (pl) |
| PL (1) | PL2076494T3 (pl) |
| PT (1) | PT2076494E (pl) |
| SI (1) | SI2076494T1 (pl) |
| TW (1) | TWI396688B (pl) |
| UA (1) | UA99109C2 (pl) |
| WO (1) | WO2008049806A1 (pl) |
| ZA (1) | ZA200902822B (pl) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0211230D0 (en) | 2002-05-16 | 2002-06-26 | Medinnova Sf | Treatment of heart failure |
| BRPI0717314A2 (pt) | 2006-10-24 | 2014-01-21 | Janssen Pharmaceutica Nv | Derivados de ácido tetra-hidro-naftaleno-1-carboxílico inibidores de mtp |
| EP2025674A1 (de) | 2007-08-15 | 2009-02-18 | sanofi-aventis | Substituierte Tetrahydronaphthaline, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel |
| EP2582709B1 (de) | 2010-06-18 | 2018-01-24 | Sanofi | Azolopyridin-3-on-derivate als inhibitoren von lipasen und phospholipasen |
| SG189019A1 (en) * | 2010-10-18 | 2013-05-31 | Cerenis Therapeutics Holding Sa | Compounds, compositions and methods useful for cholesterol mobilisation |
| ES2753386T3 (es) | 2013-03-13 | 2020-04-08 | Forma Therapeutics Inc | Derivados de 2-hidroxi-1-{4-[(4-fenil)fenil]carbonil}piperazin-1-il}etano-1-ona y compuestos relacionados como inhibidores de sintasa de ácido graso (FASN) para el tratamiento del cáncer |
| US11168068B2 (en) | 2016-07-18 | 2021-11-09 | Janssen Pharmaceutica Nv | Tau PET imaging ligands |
| US11827586B2 (en) | 2018-05-15 | 2023-11-28 | Asahi Kasei Kabushiki Kaisha | Method for producing amino acid aminoalkyl ester or inorganic acid salt thereof |
| TWI767148B (zh) | 2018-10-10 | 2022-06-11 | 美商弗瑪治療公司 | 抑制脂肪酸合成酶(fasn) |
| US10793554B2 (en) | 2018-10-29 | 2020-10-06 | Forma Therapeutics, Inc. | Solid forms of 4-(2-fluoro-4-(1-methyl-1H-benzo[d]imidazol-5-yl)benzoyl)piperazin-1-yl)(1-hydroxycyclopropyl)methanone |
| WO2024006701A1 (en) * | 2022-06-28 | 2024-01-04 | Stepan Company | Method for making dialkyl amino acid ester sulfonates |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5595872A (en) | 1992-03-06 | 1997-01-21 | Bristol-Myers Squibb Company | Nucleic acids encoding microsomal trigyceride transfer protein |
| US5739135A (en) | 1993-09-03 | 1998-04-14 | Bristol-Myers Squibb Company | Inhibitors of microsomal triglyceride transfer protein and method |
| WO1996040640A1 (en) | 1995-06-07 | 1996-12-19 | Pfizer Inc. | BIPHENYL-2-CARBOXYLIC ACID-TETRAHYDRO-ISOQUINOLIN-6-YL AMIDE DERIVATIVES, THEIR PREPARATION AND THEIR USE AS INHIBITORS OF MICROSOMAL TRIGLYCERIDE TRANSFER PROTEIN AND/OR APOLIPOPROTEIN B (Apo B) SECRETION |
| EA001539B1 (ru) | 1996-11-27 | 2001-04-23 | Пфайзер Инк. | Амиды, ингибирующие секрецию аполипопротеина в (аро в) и/или микросомного протеина переноса триглицеридов (мтр) |
| GB9826412D0 (en) | 1998-12-03 | 1999-01-27 | Glaxo Group Ltd | Chemical compounds |
| DE19963235A1 (de) | 1999-12-27 | 2001-07-05 | Boehringer Ingelheim Pharma | Substituierte Piperazinderivate, ihre Herstellung und ihre Verwendung als Arzneimittel |
| GB0013346D0 (en) | 2000-06-01 | 2000-07-26 | Glaxo Group Ltd | Therapeutic benzamide derivatives |
| FR2816940A1 (fr) * | 2000-11-23 | 2002-05-24 | Lipha | Derives de 4-(biphenylcarbonylamino)-piperidine, compositions les contenant et leur utilisation |
| BRPI0717314A2 (pt) | 2006-10-24 | 2014-01-21 | Janssen Pharmaceutica Nv | Derivados de ácido tetra-hidro-naftaleno-1-carboxílico inibidores de mtp |
-
2007
- 2007-10-03 JO JO2007410A patent/JO2653B1/en active
- 2007-10-22 SI SI200730371T patent/SI2076494T1/sl unknown
- 2007-10-22 UA UAA200902359A patent/UA99109C2/ru unknown
- 2007-10-22 CA CA2664141A patent/CA2664141C/en not_active Expired - Fee Related
- 2007-10-22 BR BRPI0717357-1A2A patent/BRPI0717357A2/pt not_active IP Right Cessation
- 2007-10-22 PT PT07821650T patent/PT2076494E/pt unknown
- 2007-10-22 PL PL07821650T patent/PL2076494T3/pl unknown
- 2007-10-22 AT AT07821650T patent/ATE475648T1/de active
- 2007-10-22 CN CN2007800393884A patent/CN101528695B/zh not_active Expired - Fee Related
- 2007-10-22 JP JP2009533800A patent/JP5506085B2/ja not_active Expired - Fee Related
- 2007-10-22 DK DK07821650.4T patent/DK2076494T3/da active
- 2007-10-22 WO PCT/EP2007/061286 patent/WO2008049806A1/en not_active Ceased
- 2007-10-22 KR KR1020097008396A patent/KR101415536B1/ko not_active Expired - Fee Related
- 2007-10-22 US US12/446,580 patent/US8114880B2/en not_active Expired - Fee Related
- 2007-10-22 NZ NZ575615A patent/NZ575615A/en not_active IP Right Cessation
- 2007-10-22 DE DE602007008124T patent/DE602007008124D1/de active Active
- 2007-10-22 EA EA200970398A patent/EA016311B1/ru not_active IP Right Cessation
- 2007-10-22 EP EP07821650A patent/EP2076494B1/en active Active
- 2007-10-22 MX MX2009004386A patent/MX2009004386A/es active IP Right Grant
- 2007-10-22 AU AU2007310925A patent/AU2007310925B2/en not_active Ceased
- 2007-10-23 AR ARP070104677A patent/AR063517A1/es not_active Application Discontinuation
- 2007-10-23 CL CL200703042A patent/CL2007003042A1/es unknown
- 2007-10-23 TW TW096139583A patent/TWI396688B/zh not_active IP Right Cessation
-
2009
- 2009-04-23 IL IL198332A patent/IL198332A/en active IP Right Grant
- 2009-04-23 ZA ZA200902822A patent/ZA200902822B/xx unknown
- 2009-05-25 NO NO20092005A patent/NO20092005L/no not_active Application Discontinuation
-
2010
- 2010-10-27 CY CY20101100974T patent/CY1111010T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL198332A0 (en) | Piperidine or piperazine substituted tetrahydro-naphthalene-1-carboxylic acid mtp inhibiting compounds | |
| HUS1900033I1 (hu) | Szubsztituált enaminokarbonil vegyületek | |
| PL2079727T3 (pl) | Inhibitory kinazy | |
| EP2085383A4 (en) | Piperidin derivatives or salts thereof | |
| PL1959951T3 (pl) | Heteroarylo-podstawione pochodne piperydyny jako inhibitory l-cpt1 | |
| IL210990A0 (en) | Piperidine derivatives as jak3 inhibitors | |
| PL2004636T3 (pl) | Podstawione związki enaminokarbonylowe jako insektycydy | |
| IL197135A0 (en) | 4-substituted phenoxyphenylacetic acid derivatives | |
| IL185399A0 (en) | Pyridyl acetic acid compounds | |
| IL194356A0 (en) | Novel cyclobutyl compounds as kinase inhibitors | |
| IL195158A0 (en) | Novel heterocyclic compounds | |
| ZA200902002B (en) | Piperidine derivatives | |
| ZA200900625B (en) | Substituted 1-(azolin-2-yl)-amino-2-aryl-1-hetaryl-ethane compounds | |
| IL188371A0 (en) | Novel piperidine derivatives | |
| ZA201000917B (en) | Piperidine derivative | |
| BRPI0913396A2 (pt) | compostos de piperidina 3- ou 4-substituídos | |
| ZA200709230B (en) | Novel piperidine derivatives | |
| ZA200904327B (en) | Substituted piperidines containing a heteroarylamide or heteroarylphenyl moiety | |
| ZA200901570B (en) | Substituted azolin-2-YL-amino compounds | |
| EP1998776A4 (en) | MACRO-HETEROCYL COMPOUNDS CONTAINING PYRIDINE AS KINASE INHIBITORS | |
| EP2128136A4 (en) | DERIVATIVE OF 2-PHENYLNICOTINIC ACID | |
| ZA200809385B (en) | Novel heterocyclic compounds | |
| EP1940411A4 (en) | MACROHETEROCYCLIC COMPOUNDS AS KINASE INHIBITORS | |
| GB0512943D0 (en) | Indazole-1-acetic acid compounds | |
| GB0619308D0 (en) | Heterocyclic compounds |